Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics, Inc. (VRDN) is a healthcare company (biotechnology) based in the United States. The share price is $29.71, down 0.30% on the day, which values the company at $3.37B. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$29.71−0.30% today
Market value
$3.37B
Funk Score
54/100
200-week average
$20.4046% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Viridian Therapeutics, Inc. in more detail

VRDN trades at -14.0× next year's expected earnings, 128.2× sales. It sits 46% above its 200-week average of $20.40.

Over the last five fiscal years Viridian Therapeutics, Inc. has compounded revenue 132.2% a year. Its Funk Score is 54 out of 100 (financial strength 5.6, profitability 2.5, growth 8.0, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold VRDN, including Julian and Felix Baker (0.2% of the portfolio).

Superinvestors holding VRDN

1 of the investors tracked here report a position in their latest 13F filing.

Viridian Therapeutics, Inc. (VRDN): questions and answers

What is Viridian Therapeutics, Inc.'s market cap?

Viridian Therapeutics, Inc. is valued at $3.37B at a share price of $29.71.

Is VRDN above its 200-week moving average?

Yes. VRDN is 45.6% above its 200-week average of $20.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Viridian Therapeutics, Inc. growing?

Over the last five fiscal years Viridian Therapeutics, Inc.'s revenue grew 132.2% a year; over ten years revenue grew 28.6% a year.

Does VRDN pay a dividend?

Viridian Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own VRDN?

In their latest quarterly filings, Julian and Felix Baker (0.2% of the portfolio) hold VRDN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Viridian Therapeutics, Inc. (VRDN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VRDN

Underlying data: Yahoo Finance; company filings with the SEC.